Pathology Doctors in Massillon, OH Accepting Medicare

1 Pathology doctors found. Showing 1 - 1

J Gregory Feczko, DO Pathology - Anatomic Pathology & Clinical Pathology Medicare: Not Enrolled in Medicare Practice Location: 400 Austin Ave Nw, Massillon, OH 44646 Phone: 330-837-7241

News Archive

Change to WA organ donor laws tabled

Under a new proposal Western Australia could become the first state in Australia to introduce ‘opt-out' organ donor laws. At present people need to opt in to be a part of national organ donor register. However, only 16 per cent of West Australians have signed to date. Under this proposal all West Australians will automatically donate their organs after they die unless they register their objection.

Viewpoints: If not the health law, then what?; Shifting Medicare costs isn't enough

When President Barack Obama's health care reform was making its way through Congress, Republicans and other opponents registered plenty of criticisms: It was too generous, too inflexible and too centralized. But such concerns were brushed aside in the push to get a bill passed. Today, it's harder to ignore those flaws. Implementation of the program has brought tougher challenges than the administration led Americans to expect. So it has been obliged to make some major concessions to reality.

Private sector involvement, measuring results are key to ending poverty

Noting two global development goals recently proposed by World Bank President Jim Kim - "to end extreme poverty, with a target reduce the global extreme poverty rate to three percent by 2030" and "to promote shared prosperity, fostering income growth of the bottom 40 percent of the population in every country" - Nigel Twose, director of International Finance Corporation's newly created development impact department, writes in the Bill & Melinda Gates Foundation's "Impatient Optimists" blog, "While many threats remain - including, most notably, the risk that climate change will reverse past gains - today many developing countries can realistically aspire to end extreme poverty within a generation."

Evolocumab drug offers no added benefit over appropriate comparator therapy

Evolocumab (trade name: Repatha) has been approved since July 2015 for two therapeutic indications: on the one hand, for hypercholesterolaemia or mixed dyslipidaemia, and on the other, for homozygous familial hypercholesterolaemia.

Secretary of Labor: Congress extends unemployment insurance, COBRA safety net programs

It is essential that Congress extend the unemployment insurance and COBRA safety net programs that are part of the American Recovery and Reinvestment Act past their current expiration date of Feb. 28. If Emergency Unemployment Compensation and full federal funding of the Extended Benefit program are not extended, 400,000 Americans will lose these vital benefits during the first couple of weeks in March.

Read more Medical News

› Verified 9 days ago